Back

Three-year chronic follow-up from the pilot study of a substernal extravascular implantable cardioverter defibrillator

3 April 2022 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: News on ICDs Implantable Cardioverter-Defibrillator (ICD) EHRA Premium Access EHRA 2022

About the speaker

Photo
Doctor Ian Crozier

Christchurch Hospital, Christchurch (New Zealand)

5 More presentations in this session

Presentation thumbnail
Incidence of premature battery depletion in subcutaneous cardioverter-defibrillator patients. Insights from a multicenter registry
Doctor J. Luker (Cologne, DE)
Abstract Slides Video
Presentation thumbnail
Impact of generic ICD programming on clinical outcomes
Mrs P. Khan (London, GB)
Abstract Slides Video
Presentation thumbnail
S-ICD in heart failure patients: real-world data from a multicenter, european analysis
Doctor M. Schiavone (Milan, IT)
Abstract Slides Video
Presentation thumbnail
In-silico optimisation of ICD defibrillation efficacy by modifying lead/can configurations using a cohort of high-resolution whole-torso heart models
Doctor S. Qian (London, GB)
Abstract Slides Video
Presentation thumbnail
Delayed detection programming significantly reduces inappropriate ICD therapies in patients with left-ventricular assist devices.
Doctor S. Hohmann (Hildesheim, DE)
Abstract Slides Video

Access the full session

Session thumbnail
News on ICDs

The Event

Event poster

EHRA 2022

3 April - 5 April 2022
You may be interested in
thumbnail
Congress Presentation
Implantable cardioverter-defibrillator
thumbnail
Congress Presentation
When to consider device therapy in HFrEF - discussion
thumbnail
Congress Session
Debate on primary prevention in ICD therapy

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources